Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inoviq Ltd (AU:IIQ)
ASX:IIQ
IIQ Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.42 - AU$0.92
Previous CloseN/A
Volume76.26K
Average Volume (3M)100.59K
Market Cap
AU$49.63M
Enterprise ValueAU$42.83M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding111,526,700
10 Day Avg. Volume115,535
30 Day Avg. Volume100,594
Standard Deviation0.53
R-Squared0.03
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)133.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Inoviq Ltd News
PremiumCompany Announcements
INOVIQ Forms Advisory Board to Boost Cancer Diagnostics and Therapeutics
PremiumCompany Announcements
INOVIQ Breakthrough in Exosome Cancer Therapy
PremiumCompany Announcements
INOVIQ Ltd Advances Breast Cancer Detection Test
PremiumCompany Announcements
Inoviq Ltd Unveils Breakthrough Ovarian Cancer Test
PremiumCompany Announcements
Inoviq Director Increases Stake with New OptionsPremiumCompany Announcements
Inoviq Ltd Issues Unquoted Equity to Boost Growth
PremiumCompany Announcements
Inoviq Ltd Advances with Successful AGM Resolutions---
Options Prices
Currently, No data available
---
Ownership Overview
IIQ FAQ
What was Inoviq Ltd’s price range in the past 12 months?
Inoviq Ltd lowest share price was AU$0.41 and its highest was AU$0.92 in the past 12 months.
What is Inoviq Ltd’s market cap?
Inoviq Ltd’s market cap is AU$49.63M.
When is Inoviq Ltd’s upcoming earnings report date?
Inoviq Ltd’s upcoming earnings report date is Sep 02, 2025 which is in 192 days.
How were Inoviq Ltd’s earnings last quarter?
Inoviq Ltd released its earnings results on Feb 20, 2025. The company reported -AU$0.033 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.033.
Is Inoviq Ltd overvalued?
According to Wall Street analysts Inoviq Ltd’s price is currently Overvalued.
Does Inoviq Ltd pay dividends?
Inoviq Ltd does not currently pay dividends.
What is Inoviq Ltd’s EPS estimate?
Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inoviq Ltd have?
Inoviq Ltd has 111,526,700 shares outstanding.
What happened to Inoviq Ltd’s price movement after its last earnings report?
Inoviq Ltd reported an EPS of -AU$0.033 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Inoviq Ltd?
Currently, no hedge funds are holding shares in AU:IIQ
---
Inoviq Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IIQ Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.46%
12-Months-Change
Fundamentals
Return on Equity
-33.10%
Trailing 12-Months
Asset Growth
0.92%
Trailing 12-Months
Company Description
Inoviq Ltd
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.
---
Technical Analysis
Biotron Limited
―
Imugene Limited
―
Patrys Limited
―
Proteomics International Laboratories Ltd.
―
Recce Pharmaceuticals Ltd.
―
---